BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 6, 2009
View Archived Issues
Recent Georgia Tech patent describes novel HDAC inhibitors
Read More
New MAPKAP-K2 (MK2) inhibitors reported in recent Novartis patent
Read More
Combination of YM-155, docetaxel and prednisone used in prostate cancer therapy
Read More
BIBF-1120 and BIBW-2992 may be used in combination in prostate cancer treatment
Read More
Bayer discloses prodrugs of apixaban for thromboembolic disorders
Read More
Merck & Co. discloses novel orexin receptor antagonists for insomnia
Read More
New HCV NS3/NS4 protease inhibitors reported in recent Gilead patent
Read More
PharmaMar licenses kahalalide F analogues to Marinomed
Read More
Catalyst halts enrollment into phase II trial of CPP-109 for methamphetamine addiction
Read More
MMI presents update on clinical development of GVX-3322 and ONCO-4417
Read More
2008 highlights at Elan
Read More
Anacor reports encouraging results from phase I AN-2718 trial
Read More
Pharmexa and Affitech enter into conditional merger agreement
Read More
MDV-3100 displays safety and antitumor activity in phase I/II trial for prostate cancer
Read More
Vertex to acquire ViroChem and its preclinical-stage polymerase inhibitors
Read More
FDA gives positive review of InNexus' IND plans for DXL-625 in NHL and CLL
Read More
Dronedarone reduces risk of hospitalization from cardiovascular events in atrial fibrillation
Read More
Meropenem/clavulanate combination inhibits extensively drug-resistant tuberculosis
Read More
Ferring launches degarelix for advanced prostate cancer
Read More
Quest presents positive results for its photosensitizer SL-052
Read More
4SC initiates phase IIa trial for 4SC-101 in Crohn's disease
Read More
Access announces results from a phase II ovarian cancer trial of ProLindac
Read More
CV Therapeutics reports phase I proof-of-concept data for CVT-3619
Read More
GlaxoSmithKline submits MAA for pazopanib in advanced kidney cancer
Read More
NICE refuses funding for advanced breast cancer treatment, Tyverb
Read More
Proteon initiates phase I/II PRT-201 study in hemodialysis patients
Read More